FILE PHOTO: A Sanofi sign outside the French drugmaker’s Paris headquarters, October 30, 2014. REUTERS/Christian Hartmann//File Photo

BOSTON (Reuters) – Sanofi SA (SASY.PA) has agreed to pay nearly $11.9 million to resolve allegations that it used a charity that helps Medicare patients cover out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of a high-priced multiple sclerosis drug.

The U.S. Justice Department on Friday said Sanofi was the latest company to settle claims stemming from an industry-wide probe of drugmakers’ financial support of patient assistance charities.

Sanofi did not admit wrongdoing as part of the settlement.

Reporting by Nate Raymond in Boston; Editing by Sandra Maler

Articles You May Like

Disney shuffles movie schedule due to virus, ‘Mulan’ set for July
Keepers, animals keep each other company at Cairo’s shuttered zoo
As Trump administration debated travel restrictions, thousands streamed in from China
The watchdogs overseeing the $2.3 trillion U.S. bailout
Airbus cuts jet production to cope with coronavirus crisis

Leave a Reply

Your email address will not be published. Required fields are marked *